image-title
Seminar in Mass & Flow Cytometry Data Analysis by Deep learning

We are pleased to announce a Seminar at the University of Zurich about the Analysis of Flow and Mass Cytometry Data with ScaiVision.

Read More
image-title
Scailyte has been selected as one of Hello Tomorrow’s Top 500 deeptech start-up

Scailyte has been selected as one of Hello Tomorrow’s Top 500 deeptech start-ups from over 4,500 applications from 119 countries!

Read More
image-title
Scailyte Selected as one of MassChallenge Switzerland’s 2018 Accelerator Top 12 Finalists

Scailyte is one of the Diamond Winners of  the Switzerland’s 2018 accelerator program. Scailyte was one of over 1’000 other startups that applied for the accelerator located in Switzerland. As a 2018 Diamond winner, Scailyte received CHF 100K in cash!

Read More
image-title
Scailyte gave a refresh to its website!

We’re excited to announce that our new and refreshed website is live. The updated site includes changes to navigation, and improved structure of our content, so you’ll get more from a quick read.

Read More
image-title
Scailyte won the JLM competition

We participated at the 18th Annual Biotech Forum in Basel and won the JLM 2018 competition!

Read More
image-title
Scailyte AG – an ETH Zurich Spin-off

We are proud to announce that Scailyte AG has been officially recognized as an ETH Spin-off.

Read More
image-title
2018 Class of Startups by MassChallenge Switzerland

Scailyte AG advanced to the final stage of MassChallenge Switzerland 2018 Class of Startups.

Read More
image-title
Peter Nestorov at Deep Tech & Entrepreneurship

Watch what Peter Nestorov said at Deep Tech & Entrepreneurship event in Paris, France.

Read More
image-title
Scailyte – one of the 101 innovative digital health startups

Scailyte has been marked as one of 101 innovative digital health, eHealth, mHealth startups in Switzerland by Dr. Hempel Digital Health Network.

Read More
image-title
Interview with Prof. Dr. Manfred Claassen

Prof. Dr. Manfred Claassen presenting his latest research at the ETH Zürich, the limitations and the future of single-cell technology.

Read More